Acurx Pharmaceuticals Inc.

0.74
-0.00 (-0.54%)
Feb 13, 2025, 9:48 AM - Market open

Acurx Pharmaceuticals Statistics

Share Statistics

Acurx Pharmaceuticals has 19.53M shares outstanding. The number of shares has increased by 16.76% in one year.

Shares Outstanding 19.53M
Shares Change (YoY) n/a
Shares Change (QoQ) 3.99%
Owned by Institutions (%) n/a
Shares Floating 16.56M
Failed to Deliver (FTD) Shares 1.75K
FTD / Avg. Volume 0.61%

Short Selling Information

The latest short interest is 474.48K, so 2.43% of the outstanding shares have been sold short.

Short Interest 474.48K
Short % of Shares Out 2.43%
Short % of Float 2.87%
Short Ratio (days to cover) 12.59

Valuation Ratios

The PE ratio is -3.33 and the forward PE ratio is -0.38.

PE Ratio -3.33
Forward PE -0.38
PS Ratio 0
Forward PS 52.9
PB Ratio 10.4
P/FCF Ratio -4.95
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Acurx Pharmaceuticals Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.53, with a Debt / Equity ratio of 0.

Current Ratio 2.53
Quick Ratio 2.53
Debt / Equity 0
Total Debt / Capitalization 0
Cash Flow / Debt 0
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -3.12% and return on capital (ROIC) is -312.38%.

Return on Equity (ROE) -3.12%
Return on Assets (ROA) -1.89%
Return on Capital (ROIC) -312.38%
Revenue Per Employee 0
Profits Per Employee -3.64M
Employee Count 4
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -74.92% in the last 52 weeks. The beta is -1.72, so Acurx Pharmaceuticals 's price volatility has been lower than the market average.

Beta -1.72
52-Week Price Change -74.92%
50-Day Moving Average 0.83
200-Day Moving Average 1.78
Relative Strength Index (RSI) 42.89
Average Volume (20 Days) 286.99K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -14.58M
Net Income -14.58M
EBITDA 0
EBIT n/a
Earnings Per Share (EPS) -1.15
Full Income Statement

Balance Sheet

The company has 7.47M in cash and 0 in debt, giving a net cash position of 7.47M.

Cash & Cash Equivalents 7.47M
Total Debt 0
Net Cash 7.47M
Retained Earnings -53.22M
Total Assets 5.98M
Working Capital -3.31B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.80M and capital expenditures 5, giving a free cash flow of -9.80M.

Operating Cash Flow -9.80M
Capital Expenditures 5
Free Cash Flow -9.80M
FCF Per Share -0.77
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ACXP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -153.33%
FCF Yield -67.14%
Dividend Details

Analyst Forecast

The average price target for ACXP is $12, which is 1500% higher than the current price. The consensus rating is "Buy".

Price Target $12
Price Target Difference 1500%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Scores

Altman Z-Score -686.57
Piotroski F-Score 1